Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic

During the geological eras, some fungi, through adaptation and/or environmental/ecological pressure, interacted directly and indirectly with humans, through occasionally harmful interaction interdependent on the individual's immunological condition. Infections caused by yeasts are underreported...

Full description

Saved in:
Bibliographic Details
Published in:Microorganisms (Basel) 2022-11, Vol.10 (11), p.2223
Main Authors: Corrêa-Junior, Dario, Andrade, Iara Bastos de, Alves, Vinicius, Araújo, Glauber R de S, Frases, Susana
Format: Article
Language:English
Subjects:
Antibiotics
Autoimmune diseases
Brazil
Candidiasis
Care and treatment
Context
Coronaviruses
Corticoids
Corticosteroids
COVID-19
Cytokine storm
Diagnosis
Drugs
Epidemics
Forecasts and trends
fungal co-infection
Fungal infections
Fungi
Health services
Hormones
Immune system
Immunology
immunomodulation
Immunosuppressive agents
Medical prognosis
Microorganisms
Mortality
Neoplasms
Pandemics
Pathogens
Patients
Pharmacology
Physiology
Respiratory diseases
Review
Severe acute respiratory syndrome coronavirus 2
Social aspects
Steroids
Transcription factors
Transplants
Viral diseases
Viral infections
Yeast
Yeasts
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During the geological eras, some fungi, through adaptation and/or environmental/ecological pressure, interacted directly and indirectly with humans, through occasionally harmful interaction interdependent on the individual's immunological condition. Infections caused by yeasts are underreported, subjugated, and underdiagnosed, and treatment is restricted to a few drugs, even after the significant progress of medicine and pharmacology. In the last centuries, antagonistically, there has been an exponential increase of immunocompromised individuals due to the use of immunosuppressive drugs such as corticosteroids, increased cases of transplants, chemotherapeutics, autoimmune diseases, neoplasms, and, more recently, coronavirus disease 2019 (COVID-19). This review aims to survey emerging and re-emerging yeast infections in the current clinical context. Currently, there is an immense clinical challenge for the rapid and correct diagnosis and treatment of systemic mycoses caused by yeasts due to the terrible increase in cases in the current context of COVID-19.
ISSN:2076-2607
2076-2607
DOI:10.3390/microorganisms10112223